Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:AUPNYSE:BTTNYSE:CDI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAUPAurinia PharmaceuticalsC$0.00C$11.77▼C$26.00C$2.15BN/A229,895 shs4.61 million shsBTTBlackrock Municipal 2030 Target Term Trust$21.92-0.1%$21.46$20.20▼$22.00N/AN/A155,483 shs40,056 shsCDICDI$8.22$0.00$4.84▼$9.65N/AN/A81,650 shsN/AA Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAUPAurinia Pharmaceuticals0.00%0.00%0.00%0.00%0.00%BTTBlackrock Municipal 2030 Target Term Trust0.00%+1.06%+1.98%+3.69%+5.44%CDICDI0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAUPAurinia PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/ABTTBlackrock Municipal 2030 Target Term TrustN/AN/AN/AN/AN/AN/AN/AN/ACDICDIN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAUPAurinia Pharmaceuticals 0.00N/AN/AN/ABTTBlackrock Municipal 2030 Target Term Trust 0.00N/AN/AN/ACDICDI 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAUPAurinia PharmaceuticalsC$57.59M0.00N/A6.75C$2.59 per share0.00BTTBlackrock Municipal 2030 Target Term Trust$38.06MN/AN/AN/AN/AN/ACDICDIN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAUPAurinia PharmaceuticalsN/A-C$1.48N/AN/AN/AN/AN/AN/AN/ABTTBlackrock Municipal 2030 Target Term TrustN/AN/A0.00∞N/AN/AN/AN/AN/ACDICDIN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAUPAurinia PharmaceuticalsN/AN/AN/AN/AN/ABTTBlackrock Municipal 2030 Target Term Trust$0.411.87%N/AN/AN/ACDICDIN/AN/AN/AN/AN/ALatest AUP, BTT, CDI, DP3D, and TBGR DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/3/2025BTTBlackrock Municipal 2030 Target Term Trustmonthly$0.04642.5%7/15/20257/15/20258/1/20256/4/2025BTTBlackrock Municipal 2030 Target Term Trustmonthly$0.04642.6%6/13/20256/13/20257/1/20255/5/2025BTTBlackrock Municipal 2030 Target Term Trustmonthly$0.04642.6%5/15/20255/15/20256/2/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAUPAurinia Pharmaceuticals2.6911.9311.02BTTBlackrock Municipal 2030 Target Term TrustN/AN/AN/ACDICDIN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAUPAurinia PharmaceuticalsN/ABTTBlackrock Municipal 2030 Target Term TrustN/ACDICDI35.88%Insider OwnershipCompanyInsider OwnershipAUPAurinia PharmaceuticalsN/ABTTBlackrock Municipal 2030 Target Term TrustN/ACDICDI8.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAUPAurinia Pharmaceuticals300128.40 millionN/ANot OptionableBTTBlackrock Municipal 2030 Target Term TrustN/AN/AN/ANot OptionableCDICDIN/AN/AN/ANot OptionableAUP, BTT, CDI, DP3D, and TBGR HeadlinesRecent News About These CompaniesGot a used 2010 Mercedes GL350 CDI: Purchase story & first impressionsJuly 5 at 3:08 AM | team-bhp.comTTamboran Resources Reports Decrease in CDIs IssuedJuly 3 at 3:44 AM | tipranks.comAnteris Technologies Updates CDI Issuance for June 2025July 3 at 3:44 AM | tipranks.comPreventive Vancomycin Shows Promise Against Recurrent C. DifficileJuly 2, 2025 | medpagetoday.comMResults for "cdi 5200 in sri lanka"July 2, 2025 | gsmarena.comGModine acquires Minnesota-based Climate by Design InternationalJuly 2, 2025 | biztimes.comBLouisiana Tech, Bossier Chamber lead CDI for economic growthJuly 2, 2025 | yahoo.comModine acquires IAQ technologyJuly 1, 2025 | climatecontrolnews.com.auCCDI Central in Louisiana Completes Session II in Bossier CityJuly 1, 2025 | bossierpress.comBCalifornia appellate court affirms state regulator's authority to place insurers into conservationJuly 1, 2025 | insurancebusinessmag.comIFlorida Entrepreneur Cole Peacock Featured in In-Depth BusinessJune 30, 2025 | theglobeandmail.comThe California Insurance Company (CIC) Weighs Options Following Latest Turn in Six-Year Battle with California Department of Insurance (CDI)June 30, 2025 | finance.yahoo.comFecal Microbiota Transplantation Could Be First-Line Therapy for C difficileJune 27, 2025 | infectiousdiseaseadvisor.comISwitch Metals upbeat after year of transformationJune 27, 2025 | sharecast.comSCollaboration between antibiotic stewardship, infection prevention is imperativeJune 27, 2025 | healio.comHNew Orleans Horse Betting to Resume in NovemberJune 27, 2025 | covers.comCTailored TB treatment based on disease severity may improve patient outcomesJune 27, 2025 | msn.comFecal Microbiota Transplantation Could Be First-Line Therapy for C. DifficileJune 25, 2025 | msn.comDeal approved to keep horses racing at Fair GroundsJune 25, 2025 | neworleanscitybusiness.comNFair Grounds Meet to Move Forward After Dates ApprovedJune 24, 2025 | bloodhorse.comBMedia Sentiment Over TimeAUP, BTT, CDI, DP3D, and TBGR Company DescriptionsAurinia Pharmaceuticals TSE:AUPAurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need in Japan and China. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.Blackrock Municipal 2030 Target Term Trust NYSE:BTT$21.92 -0.03 (-0.14%) As of 07/3/2025 03:30 PM EasternBlackrock Municipal 2030 Target Term Trust is a closed end fixed income mutual fund launched by BlackRock, Inc. The fund is managed by by BlackRock Advisors, LLC. It invests in fixed income markets. The fund invests primarily in investment grade municipal bonds that are exempt from regular federal income tax. It was formerly known as BlackRock Municipal Target Term Trust. Blackrock Municipal 2030 Target Term Trust was formed on August 30, 2012 and is domiciled in the United States.CDI NYSE:CDICDI Corp. provides engineering, information technology and staffing solutions. The Company operates in three segments: Global Engineering and Technology Solutions (GETS), Professional Staffing Services (PSS) and Management Recruiters International (MRI). It provides staffing services through its MRINetwork of franchisees. The GETS segment provides engineering and information technology solutions that involve the production of deliverable work products or services performed at its facility or at a customer's facility. The PSS segment provides technical and professional personnel for discrete periods of time to augment the customer's workforce in times of project, seasonal, peak period or business cycle needs. The MRI segment is a global franchisor that does business as MRINetwork and provides the use of its trademarks, business systems and training and support services to its franchisees. It serves the oil, gas and chemicals, aerospace and industrial equipment, and hi-tech industries. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Correction Equals Opportunity in Domino’s Pizza Stock Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
